Trial intelligence / Profile preview

Erythropoietin Alpha in Anemia with HFPEF

NCT00286182Phase 2Completed

Start
Jul 2007
Primary completion
Nov 2012
Modality
Biologic, rProtein (Recombinant Protein)
Countries
1
01

Overview

A Phase 2 trial of epoetin alfa in anemia. Started Jul 2007; status: completed.

02

Drugs

epoetin alfa
03

Conditions

anemia

Beyond the preview

Go deeper on NCT00286182.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00286182.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call